CORC

浏览/检索结果: 共30条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
收藏  |  浏览/下载:45/0  |  提交时间:2022/12/22
Exploratory hrd and PD-L1 analysis of l-MOCA study: Olaparib maintenance monotherapy in Asian patients with platinum-sensitive relapsed ovarian cancer. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Ma, Ding;  Gao, Qing-Lei;  Zhu, Jianqing;  Zhao, Weidong;  Huang, Yi
收藏  |  浏览/下载:48/0  |  提交时间:2022/12/23
Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling
收藏  |  浏览/下载:48/0  |  提交时间:2021/11/01
Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
收藏  |  浏览/下载:55/0  |  提交时间:2021/11/01
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin
收藏  |  浏览/下载:44/0  |  提交时间:2021/11/01
Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wang, Jing;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin
收藏  |  浏览/下载:26/0  |  提交时间:2022/01/10
Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wu, Lingying;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin
收藏  |  浏览/下载:28/0  |  提交时间:2022/01/10
Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2021 期刊论文
NUCLEIC ACIDS RESEARCH, 2021, 卷号: 49, 期号: D1, 页码: D18-D28
作者:  Xue, Yongbiao;  Bao, Yiming;  Zhang, Zhang;  Zhao, Wenming;  Xiao, Jingfa
收藏  |  浏览/下载:95/0  |  提交时间:2021/12/01
MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα. 期刊论文
Life Sciences, 2019, 卷号: Vol.217, 页码: 57-69
作者:  Liu, Xiaobin;  Zhang, Lufang;  Tong, Yingna;  Yu, Man;  Wang, Meng
收藏  |  浏览/下载:13/0  |  提交时间:2019/12/17
MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ER alpha 期刊论文
LIFE SCIENCES, 2019, 卷号: Vol.217, 页码: 57-69
作者:  Liu, Xiaobin;  Zhang, Lufang;  Tong, Yingna;  Yu, Man;  Meng, Wang
收藏  |  浏览/下载:15/0  |  提交时间:2019/12/17


©版权所有 ©2017 CSpace - Powered by CSpace